In endometrial cancer, ENO1 silencing mediated the inactivation of PI3K/AKT signaling and its downstream signal suppression, including glycolysis, cell-cycle progression, and EMT-associated genes, by modulating p85.56 This evidence concerns the gene ENO1 and endometrial cancer.